Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

EyePoint Pharmaceuticals Inc. buy Chardan Capital

Start price
€8.25
28.06.24 / 50%
Target price
€26.15
28.06.25
Performance (%)
14.88%
Price
€9.48
12.07.24
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital currently has a performance of 14.88%. This prediction currently runs until 28.06.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w
EyePoint Pharmaceuticals Inc. 20.955%
iShares Core DAX® 1.776%
iShares Nasdaq 100 -1.037%
iShares Nikkei 225® -0.335%
iShares S&P 500 0.854%

Comments by Chardan_Capital for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 14.88%
Target price 26.149
Change
Ends at 28.06.25

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $28.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat

Stopped prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.92
07.05.24
€25.98
07.05.25
-4.42%
12.07.24

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.30
03.08.23
€20.11
03.08.24
-16.58%
12.07.24

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.92
03.03.23
€19.79
03.03.24
797.26%
04.03.24